ArriVent BioPharma所有資訊

ArriVent BioPharma | 8-K/A：重大事件(修正)

07/09 17:11 (美東)

ArriVent BioPharma | 8-K/A：重大事件(修正)

07/09 17:06 (美東)

ArriVent BioPharma | 8-K：重大事件

06/05 07:21 (美東)

ArriVent BioPharma | 4：持股變動聲明-董事 Hohneker John

05/20 17:36 (美東)

ArriVent BioPharma | 3：首次持股聲明-董事 Hohneker John

05/20 17:31 (美東)

ArriVent BioPharma | 8-K：重大事件

05/16 16:16 (美東)

ArriVent BioPharma | 10-Q：季度報表

05/08 08:03 (美東)

ArriVent BioPharma | 8-K：ArriVent BioPharma 公佈2024年第一季度財務業績

05/08 08:03 (美東)

ArriVent BioPharma | 4：持股變動聲明-董事 Peterson Kristine

04/23 16:09 (美東)

ArriVent BioPharma | 3：首次持股聲明-董事 Peterson Kristine

04/23 16:09 (美東)

ArriVent BioPharma | 8-K：重大事件

04/22 16:13 (美東)

ArriVent BioPharma | 8-K：重大事件

03/28 22:40 (美東)

ArriVent BioPharma | 10-K：年度報表

03/28 17:23 (美東)

ArriVent BioPharma | SC 13G：超過5%持股股東披露文件-Yi Shi(6.4%),LAV Fund VI, L.P. (“LAVVI”)(6.2%)等

02/13 17:33 (美東)

ArriVent BioPharma | SC 13D：超過5%持股股東披露文件-OrbiMed Advisors LLC(9.1%),OrbiMed Capital GP VIII LLC(4.5%)等

02/05 16:44 (美東)

ArriVent BioPharma | S-8：員工福利計劃證券登記

02/02 16:14 (美東)

ArriVent BioPharma | 4：持股變動聲明-股東 HILLHOUSE INVESTMENT MANAGEMENT, LTD.

02/01 16:53 (美東)

ArriVent BioPharma | 4：持股變動聲明-董事 ORBIMED ADVISORS LLC

01/31 16:18 (美東)

ArriVent BioPharma | 4：持股變動聲明-董事 HEALY JAMES

01/31 16:14 (美東)

ArriVent BioPharma | 4：持股變動聲明-董事 GORDON CARL L

01/31 16:13 (美東)